Skip to main content
Top
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | Diabetic Retinopathy | Research

Circ_001209 aggravates diabetic retinal vascular dysfunction through regulating miR-15b-5p/COL12A1

Authors: Fang Wang, Meixia Zhang

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Objective

Diabetic retinopathy, a common complication of diabetes mellitus and a major cause of blindness. circRNAs spongs target miRNA and thus influencing mRNA expression in DR. We investigated the mechanism of circ_001209 in regulating diabetic retinal vascular dysfunction.

Methods

QRT-PCR analysis was performed to detect the expression of miR-15b-5p, COL12A1 and circ_001209 in human retinal vascular endothelial cells (HRVECs) under high glucose conditions. Western blot assay, wound healing assay, transwell assay and tube formation were used to explore the roles of circ_001209/miR-15b-5p/COL12A1 in retinal vascular dysfunction. Bioinformatics analysis and luciferase reporter, RNA-FISH, and overexpression assays were performed to reveal the mechanisms of the circ_001209/miR-15b-5p/COL12A1 interaction. TUNEL staining and H&E staining were used to evaluate the pathological changes in streptozotocin (STZ)-induced DR in rats.

Results

Downregulation of miR-15b-5p under HG conditions promoted proliferation, migration, and tube formation of HRVECs. QRT-PCR and western blot results revealed that miR-15b-5p affected the HRVECs function through targeting COL12A1. Under HG conditions, circ_001209, which acts as a sponge of miR-15b-5p, is upregulated. Besides, overexpression of circ_001209 can affect HRVEC function and aggravate retinal injury in diabetic rats.

Conclusion

Upregulation of circ_001209 contributes to vascular dysfunction in diabetic retinas through regulating miR-15b-5p and COL12A1, providing a potential treatment strategy for diabetic retinopathy.
Literature
1.
go back to reference Cunha-Vaz J, Conceicao L, et al. Phenotypes and biomarkers of diabetic retinopathy. Progr Retinal Eye Res. 2014;41(1):90–111.CrossRef Cunha-Vaz J, Conceicao L, et al. Phenotypes and biomarkers of diabetic retinopathy. Progr Retinal Eye Res. 2014;41(1):90–111.CrossRef
2.
go back to reference Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60(5):428–31.CrossRef Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60(5):428–31.CrossRef
3.
go back to reference Lois N, McCarter RV, O’Neill C, Medina RJ, Stitt AW. Endothelial progenitor cells in diabetic retinopathy. Front Endocrinol (Lausanne). 2014;5:44.CrossRef Lois N, McCarter RV, O’Neill C, Medina RJ, Stitt AW. Endothelial progenitor cells in diabetic retinopathy. Front Endocrinol (Lausanne). 2014;5:44.CrossRef
4.
go back to reference Lee BJ, Byeon HE, Cho CS, et al. Histamine causes an imbalance between pro-angiogenic and anti-angiogenic factors in the retinal pigment epithelium of diabetic retina via H4 receptor/p38 MAPK axis. BMJ Open Diabetes Res Care. 2020;8:e001710.CrossRef Lee BJ, Byeon HE, Cho CS, et al. Histamine causes an imbalance between pro-angiogenic and anti-angiogenic factors in the retinal pigment epithelium of diabetic retina via H4 receptor/p38 MAPK axis. BMJ Open Diabetes Res Care. 2020;8:e001710.CrossRef
5.
go back to reference Min JW, Kim HD, Park SY, et al. Relationship between retinal capillary nonperfusion area and renal function in patients with type 2 diabetes. Invest Ophthalmol Vis Sci. 2020;61:14.CrossRef Min JW, Kim HD, Park SY, et al. Relationship between retinal capillary nonperfusion area and renal function in patients with type 2 diabetes. Invest Ophthalmol Vis Sci. 2020;61:14.CrossRef
6.
go back to reference Al-Khersan H, Russell JF, Lazzarini TA, et al. Comparison between graders in detection of diabetic neovascularization with swept source OCT angiography and fluorescein angiography. Am J Ophthalmol. 2020;224:292–300.CrossRef Al-Khersan H, Russell JF, Lazzarini TA, et al. Comparison between graders in detection of diabetic neovascularization with swept source OCT angiography and fluorescein angiography. Am J Ophthalmol. 2020;224:292–300.CrossRef
7.
go back to reference Zhao Q, Zhou F, Zhang Y, et al. Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;148:23–31.CrossRef Zhao Q, Zhou F, Zhang Y, et al. Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;148:23–31.CrossRef
8.
go back to reference Zeng Y, He T, Liu J, et al. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Medicine (Baltimore). 2020;99:e23314.CrossRef Zeng Y, He T, Liu J, et al. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Medicine (Baltimore). 2020;99:e23314.CrossRef
9.
go back to reference Wang J, Liang S, Guangming W, et al. A novel microRNA-365/SIRT1/β-catenin/GLUT1 signaling axis affects the initiation of diabetic retinopathy. Diabetes Metab Res Rev. 2020; e3428. Wang J, Liang S, Guangming W, et al. A novel microRNA-365/SIRT1/β-catenin/GLUT1 signaling axis affects the initiation of diabetic retinopathy. Diabetes Metab Res Rev. 2020; e3428.
10.
go back to reference Xue L, Xiong C, Li J, et al. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway .Biosci Rep. 2020;40. Xue L, Xiong C, Li J, et al. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway .Biosci Rep. 2020;40.
11.
go back to reference Ji Q, Han J, Wang L, et al. MicroRNA-34a promotes apoptosis of retinal vascular endothelial cells by targeting SIRT1 in rats with diabetic retinopathy. Cell Cycle. 2020;19:2886–96.CrossRef Ji Q, Han J, Wang L, et al. MicroRNA-34a promotes apoptosis of retinal vascular endothelial cells by targeting SIRT1 in rats with diabetic retinopathy. Cell Cycle. 2020;19:2886–96.CrossRef
12.
go back to reference Ye E-A, Steinle JJ. miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3. J Neuroinflammation. 2015;12:44.CrossRef Ye E-A, Steinle JJ. miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3. J Neuroinflammation. 2015;12:44.CrossRef
13.
go back to reference Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA. 2014;20:1829–42.CrossRef Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA. 2014;20:1829–42.CrossRef
14.
go back to reference Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22–37.CrossRef Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22–37.CrossRef
15.
go back to reference Bai Y, Wang J, He Z, Yang M, Li L, Jiang H. Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor beta (TGF-beta)/smad pathway and pro-inflammatory cytokines. Med Sci Monit. 2019;25:3069–76.CrossRef Bai Y, Wang J, He Z, Yang M, Li L, Jiang H. Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor beta (TGF-beta)/smad pathway and pro-inflammatory cytokines. Med Sci Monit. 2019;25:3069–76.CrossRef
16.
go back to reference Zhao L, Li J, Liu Y, et al. Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway. Cancer Biol Med. 2018;15:400–14.CrossRef Zhao L, Li J, Liu Y, et al. Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway. Cancer Biol Med. 2018;15:400–14.CrossRef
17.
go back to reference Wang Q, Zhang F, Lei Y, et al. microRNA-322/424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2/HIF-1α pathway. Life Sci. 2020;266:118819.CrossRef Wang Q, Zhang F, Lei Y, et al. microRNA-322/424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2/HIF-1α pathway. Life Sci. 2020;266:118819.CrossRef
18.
go back to reference Gu C, Zhang H, Gao Y. Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1. J Cell Physiol. 2020;236:5036–51.CrossRef Gu C, Zhang H, Gao Y. Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1. J Cell Physiol. 2020;236:5036–51.CrossRef
19.
go back to reference Chen J, Li X, Yang L, et al. CircASH2L promotes ovarian cancer tumorigenesis, angiogenesis, and lymphangiogenesis by regulating the miR-665/VEGFA axis as a competing endogenous RNA. Front Cell Dev Biol. 2020;8:595585.CrossRef Chen J, Li X, Yang L, et al. CircASH2L promotes ovarian cancer tumorigenesis, angiogenesis, and lymphangiogenesis by regulating the miR-665/VEGFA axis as a competing endogenous RNA. Front Cell Dev Biol. 2020;8:595585.CrossRef
20.
go back to reference Yu L-M, Di W-C, Dong X, et al. Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation. Biochim Biophys Acta Mol Basis Dis. 2018;1864:563–78.CrossRef Yu L-M, Di W-C, Dong X, et al. Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation. Biochim Biophys Acta Mol Basis Dis. 2018;1864:563–78.CrossRef
21.
go back to reference Klaassen I, Van Noorden CJF, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013;34:19–48.CrossRef Klaassen I, Van Noorden CJF, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013;34:19–48.CrossRef
22.
go back to reference Dou X, Duerfeldt AS. Small-molecule modulation of PPARs for the treatment of prevalent vascular retinal diseases. Int J Mol Sci. 2020;21:9251.CrossRef Dou X, Duerfeldt AS. Small-molecule modulation of PPARs for the treatment of prevalent vascular retinal diseases. Int J Mol Sci. 2020;21:9251.CrossRef
23.
go back to reference Zhu K, Hu X, Chen H, et al. Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI. EBioMedicine. 2019;49:341–53.CrossRef Zhu K, Hu X, Chen H, et al. Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI. EBioMedicine. 2019;49:341–53.CrossRef
24.
go back to reference Zeng Y, Cui Z, Liu J, et al. MicroRNA-29b-3p promotes human retinal microvascular endothelial cell apoptosis via blocking SIRT1 in diabetic retinopathy. Front Physiol. 2019;10:1621.CrossRef Zeng Y, Cui Z, Liu J, et al. MicroRNA-29b-3p promotes human retinal microvascular endothelial cell apoptosis via blocking SIRT1 in diabetic retinopathy. Front Physiol. 2019;10:1621.CrossRef
25.
go back to reference Karagiannis GS, Berk A, Dimitromanolakis A, et al. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. Mol Oncol. 2013;7:826–39.CrossRef Karagiannis GS, Berk A, Dimitromanolakis A, et al. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. Mol Oncol. 2013;7:826–39.CrossRef
26.
go back to reference Karagiannis GS, Petraki C, Prassas I, et al. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget. 2012;3:267–85.CrossRef Karagiannis GS, Petraki C, Prassas I, et al. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget. 2012;3:267–85.CrossRef
27.
go back to reference Kumar S, Pandey M, Sharawat SK. Biological functions of long noncoding RNAs and circular RNAs in small-cell lung cancer. Epigenomics. 2020;12:1751–63.CrossRef Kumar S, Pandey M, Sharawat SK. Biological functions of long noncoding RNAs and circular RNAs in small-cell lung cancer. Epigenomics. 2020;12:1751–63.CrossRef
28.
go back to reference Wu Z, Liu B, Ma Y, et al. Discovery and validation of hsa_circ_0001953 as a potential biomarker for proliferative diabetic retinopathy in human blood. Acta Ophthalmol. 2020;99:306–13.CrossRef Wu Z, Liu B, Ma Y, et al. Discovery and validation of hsa_circ_0001953 as a potential biomarker for proliferative diabetic retinopathy in human blood. Acta Ophthalmol. 2020;99:306–13.CrossRef
29.
go back to reference Zou J, Liu K-C, Wang W-P, et al. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy. Life Sci. 2020;256:117888.CrossRef Zou J, Liu K-C, Wang W-P, et al. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy. Life Sci. 2020;256:117888.CrossRef
30.
go back to reference Jiang Q, Liu C, Li C-P, et al. Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction. J Clin Invest. 2020;130:3833–47.CrossRef Jiang Q, Liu C, Li C-P, et al. Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction. J Clin Invest. 2020;130:3833–47.CrossRef
Metadata
Title
Circ_001209 aggravates diabetic retinal vascular dysfunction through regulating miR-15b-5p/COL12A1
Authors
Fang Wang
Meixia Zhang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-02949-5

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.